Research: Single Dose Moxidectin vs Ivermectin for Onchocerca Volvulus Infection 21 Jan, 2018 | 16:59h | UTC Single dose moxidectin versus ivermectin for Onchocerca volvulus infection in Ghana, Liberia, and the Democratic Republic of the Congo: a randomised, controlled, double-blind phase 3 trial – The Lancet (free) Editorial: A new powerful drug to combat river blindness (free)